ZBH: HAGEMANN ROBERT discloses securities transactions

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

HAGEMANN ROBERT

Reporting filer

HAGEMANN ROBERT reported Grant or award in ZIMMER BIOMET HOLDINGS, INC.: 306.066 units of Phantom Stock Units (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 2, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Phantom Stock Units (derivative)	HAGEMANN ROBERT	2026-09-30	A	Grant or award	306.066	0	33,660.84	2 days	Filed terms security Title: Phantom Stock Units id: F1 conversion Or Exercise Price: 89.85 id: F2 transaction Date: 2026-09-30 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 306.066 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F3 id: F3 underlying Security Title: Common Stock underlying Security Shares: 306.066 shares Owned Following Transaction: 33660.840 id: F4 direct Or Indirect Ownership: D nature Of Ownership:

Phantom Stock Units (derivative)

Owner: HAGEMANN ROBERT
Date: 2026-09-30
Code: A
Action: Grant or award
Quantity: 306.066
Price: 0
Following holdings: 33,660.84
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Phantom Stock Units
id: F1
conversion Or Exercise Price: 89.85
id: F2
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 306.066
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F3
id: F3
underlying Security Title: Common Stock
underlying Security Shares: 306.066
shares Owned Following Transaction: 33660.840
id: F4
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
HAGEMANN ROBERT: Director.
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
F4: Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Phantom Stock Units (derivative)

HAGEMANN ROBERT

2026-09-30

Grant or award

306.066

33,660.84

2 days

Filed terms

security Title: Phantom Stock Units
id: F1
conversion Or Exercise Price: 89.85
id: F2
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 306.066
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F3
id: F3
underlying Security Title: Common Stock
underlying Security Shares: 306.066
shares Owned Following Transaction: 33660.840
id: F4
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

HAGEMANN ROBERT: Director.

F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4: Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.